Across the recent three months, 7 analysts have shared their insights on Castle Biosciences (NASDAQ:CSTL), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 4 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 3 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $40.29, with a high estimate of $44.00 and a low estimate of $36.00. This upward trend is evident, with the current average reflecting a 14.17% increase from the previous average price target of $35.29.
Exploring Analyst Ratings: An In-Depth Overview
The analysis of...
Login or create a forever free account to read this news
Sign up/Log in
